EC Healthcare

SHSC:2138 Voorraadrapport

Marktkapitalisatie: HK$900.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

EC Healthcare Toekomstige groei

Future criteriumcontroles 4/6

EC Healthcare is forecast to grow earnings and revenue by 97.7% and 11.5% per annum respectively. EPS is expected to grow by 97.6% per annum. Return on equity is forecast to be 11.8% in 3 years.

Belangrijke informatie

97.7%

Groei van de winst

97.6%

Groei van de winst per aandeel

Consumer Services winstgroei21.9%
Inkomstengroei11.5%
Toekomstig rendement op eigen vermogen11.8%
Dekking van analisten

Low

Laatst bijgewerkt26 Jul 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

SHSC:2138 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (HKD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
3/31/20265,289237N/A1,1701
3/31/20254,806159N/A9902
3/31/20244,211-19528689N/A
12/31/20234,157-11422709N/A
9/30/20234,104-4317729N/A
6/30/20233,98933255667N/A
3/31/20233,87570193605N/A
12/31/20223,62293162499N/A
9/30/20223,369117132392N/A
6/30/20223,144157240500N/A
3/31/20222,920198348608N/A
12/31/20212,823253479684N/A
9/30/20212,727309610760N/A
6/30/20212,404251541690N/A
3/31/20212,080193472621N/A
12/31/20201,854163487597N/A
9/30/20201,627133503573N/A
6/30/20201,788210505574N/A
3/31/20201,949287507576N/A
12/31/20192,023325273452N/A
9/30/20192,09836440327N/A
6/30/20191,975363-5283N/A
3/31/20191,852361-49238N/A
12/31/20181,715355108278N/A
9/30/20181,578348265317N/A
6/30/20181,450314269320N/A
3/31/20181,322279272324N/A
12/31/20171,253266N/A302N/A
9/30/20171,183253N/A280N/A
6/30/20171,079227N/A230N/A
3/31/2017975201N/A180N/A
12/31/2016878170N/A123N/A
9/30/2016780139N/A66N/A
6/30/2016744144N/A71N/A
3/31/2016708149N/A76N/A
12/31/2015688166N/A105N/A
9/30/2015668183N/A134N/A
6/30/2015645179N/A146N/A
3/31/2015621174N/A159N/A
3/31/201449081N/A145N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 2138 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).

Winst versus markt: 2138 is forecast to become profitable over the next 3 years, which is considered above average market growth.

Hoge groeiwinsten: 2138 is expected to become profitable in the next 3 years.

Omzet versus markt: 2138's revenue (11.5% per year) is forecast to grow faster than the Hong Kong market (7.3% per year).

Hoge groei-inkomsten: 2138's revenue (11.5% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: 2138's Return on Equity is forecast to be low in 3 years time (11.8%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y